RecruitingNot ApplicableNCT05163301

Alcohol Research in HIV: Relapse Prevention

Alcohol Research Consortium in HIV: Relapse Prevention Arm


Sponsor

Johns Hopkins University

Enrollment

150 participants

Start Date

Mar 27, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is developing and testing a relapse prevention program for people living with HIV who have a history of alcohol use disorder. The aim is to support people who have reduced their drinking to maintain that progress. **You may be eligible if...** - You have a confirmed HIV diagnosis - You are 18 years of age or older - You receive HIV care at the Johns Hopkins HIV Clinic - You have a lifetime history of alcohol use disorder - Your recent records show periods of both lower-risk drinking and episodes of heavier drinking in the past 3 years - You are currently drinking at low-risk levels or are abstaining **You may NOT be eligible if...** - You are currently in a mental health crisis (suicidal, psychotic, or unable to consent) - You do not speak English (interventions are only available in English) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALRelapse Prevention Intervention

2 session intervention to address relapse prevention among people with HIV who have an alcohol use disorder


Locations(1)

Johns Hopkins School of Medicine

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05163301


Related Trials